Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 15, 2005 (Vol. 25, No. 2)

Pharmacogenomic Tests for Breast Cancer

Using Genomic and Proteomic Data To Make More Accurate Predictions

  • A test just on the market by Genomic Health (www.genomichealth.com) predicts the recurrence risk for individual breast cancer patients and, importantly, which patients may benefit from tamoxifren and which might not. The information, presented at last month's "San Antonio Breast Cancer Symposium," helps resolve the conundrum faced by ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.